Standalone Sandoz And Biocon’s Biosimilars: 2022’s Biggest Deals

Apotex Moves From Family To Private Equity, Among Other Transactions

 
• By Dean Rudge
  
Tracks
Several of industry's major players made moves in 2022 • Source: Shutterstock

More from Deal-Making

More from In Vivo